RECRUITING

Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is an observational prospective study in a cohort of healthy subjects who are enrolled using convenience and snowballing sampling. The aims of the study is to demonstrate the efficacy of using NeuraLight system to capture oculometric data from healthy participants and to validate the data capture of NeuraLight oculometric measurements as compared with a validated eye-tracker system in subjects who meet the inclusion criteria and who provide a signed Informed Consent.

Official Title

Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures

Quick Facts

Study Start:2022-07-22
Study Completion:2026-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05476523

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Men and women ages between 18 and 90 years old
  2. * Normal or corrected vision
  3. * Ability to follow instructions
  4. * Willing and able to sign an informed consent form
  1. * Inability to sit for 20 minutes on a chair in a calm manner
  2. * Personal or 1st degree relative history of epilepsy
  3. * Additional neurological diseases
  4. * Drug or alcohol abuse

Contacts and Locations

Study Contact

Eitan Raveh, PhD
CONTACT
+972-58-6277947
eitan@neuralight.ai

Principal Investigator

Eitan Raveh, PhD
PRINCIPAL_INVESTIGATOR
NeuraLight

Study Locations (Sites)

NeuraLight
Wilmington, Delaware, 19801
United States

Collaborators and Investigators

Sponsor: NeuraLight

  • Eitan Raveh, PhD, PRINCIPAL_INVESTIGATOR, NeuraLight

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-07-22
Study Completion Date2026-12-31

Study Record Updates

Study Start Date2022-07-22
Study Completion Date2026-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Eye Movement